Ann Tucker
- Feb 5, 2021
- 1 min read

ONDCP: Elimination of X-Waiver Requirement Announced Prematurely

Office of National Drug Control Policy: "On January 14, 2021, HHS announced forthcoming Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder. Unfortunately, the announcement was made prematurely. Therefore, the Guidelines previously announced cannot be issued at this time. However, HHS and ONDCP are committed to working with interagency partners to examine ways to increase access to buprenorphine, reduce overdose rates and save lives."

Recent Posts

See All

Oversight Hearing Held on ONDCP Reauthorization

U.S. House | This week, the House Oversight and Accountability Committee held a hearing on “Oversight and Reauthorization of the Office of National Drug Control Policy." Dr. Rahul Gupta, ONDCP Directo

Senate Appropriators Advance Modest Substance Use, Mental Health Block Grant Increases in Spending

U.S. Senate | Last week, the Senate Appropriations Committee passed a FY24 funding bill for several priority agencies including the Substance Abuse and Mental Health Services Administration (SAMHSA),

Between April-May 2023, Nearly 14% of Louisiana 988 Calls Went Unanswered

Axios [2-Aug] | Nearly 14% of the 5,065 988 calls made across Louisiana went unanswered by in-state counselors between April and May, per a new analysis from health research outlet KFF. Those calls we

ONDCP: Elimination of X-Waiver Requirement Announced Prematurely

Recent Posts

Subscribe to the CLASPP Newsletter

Email:

Phone: